OEM News

Vantive to Invest Over $1B in Digital Kidney Care Therapies

The company plans to develop digitally-enabled dialysis and critical care products and services.

Vantive, an organ therapy company with a legacy of kidney innovation, will invest over $1 billion over the next five years into expanding R&D and production capacity. The investment is meant to power innovation of digitally-enabled therapies to enhance care access, experience, and outcomes.

The company plans to develop digitally-enabled dialysis and critical care products and services. With these solutions, Vantive hopes to power earlier, more informed clinical decision-making. The company also hopes to minimize care disruption, move kidney care management from episodic to proactive, and boost patient-care team connectivity.

At the 62nd European Renal Association (ERA) Congress, Vantive will highlight products, digital solutions, services, and studies.

The Sharesource Connectivity Platform

Since the tech was introduced a decade ago, Sharesource has supported more than 100 million home dialysis treatments around the world. The two-way remote patient management platform lets patients using at-home automated peritoneal dialysis (APD) remain connected with care teams during treatment.

The company will present studies assessing implementation of Sharesource Analytics 1.0 in peritoneal dialysis (PD) services, as well as how remote patient management tools can impact a PD care team’s efficiency and outcomes.

Digital Health Solutions for the ICU

Vantive’s PrisMax, the outcomes of 30 years of continuous renal replacement therapy (CRRT) innovation and ICU partnership, was built to address challenges of ICU clinicians to treat clinically ill patients. Using TrueVue Connect digital health solutions, the tech offers data to enable CRRT management and multi-organ support in the acute setting.

Virtual Reality Training and Vantive Learning Services

The company’s Learning Services offer on-demand training to support clinicians in using its therapies. This includes Vantive’s VR-based educational training, which provides immersive training for using PrisMax to treat critical kidney injuries. The VR tech features a virtual 3D model of PrisMax, removing the need to reduce frontline service to train staff.

“As we prepare to take part in our first ERA Congress as Vantive, we are proud to unveil this significant investment, which underscores our commitment to shaping the future of kidney care and vital organ support,” said Chris Toth, CEO of Vantive. “Better outcomes are possible when care is more accessible, more intuitive, and more connected to the needs of patients as well as the realities of the modern healthcare ecosystem. That’s why we are focused on transforming where and how therapy is delivered – from life-saving critical care for patients in a hospital, to life-sustaining dialysis for patients at home.”


Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters